Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.8.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Operating activities:      
Net loss $ (613) $ (74,874) $ (50,122)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation 101 201 192
Stock-based compensation 614 548 2,934
Change in fair value of derivative liabilities (907) (2,603) 9,916
Deferred income tax (6,880) (29,413) (15,267)
Loss on return of escrowed shares 1,686
Impairment loss on mortgage note receivable 1,177
Impairment on IPR&D 92,396 38,665
Loss on disposal of equipment 100
Changes in operating assets and liabilities:      
Accounts receivable 20 11
Prepaid expenses and other current assets 413 (76) (212)
Accounts payable and accrued expenses 281 (2,022) 1,891
Deferred rent (32) 2
Net cash used in operating activities (6,903) (14,655) (10,317)
Investing activities      
Purchase of property and equipment (40) (51) (339)
Interest earned on mortgage note receivable 33
Principal payments received on mortgage note receivable 21 77
Net cash provided by (used in) investing activities (40) 3 (262)
Financing activities      
Proceeds from exercise of stock options 80 3 23
Proceeds from issuance of convertible notes payable 1,000
Proceeds from issuance of common stock 3,000 9,013 15,862
Net cash provided by financing activities 4,080 9,016 15,885
Net (decrease) increase in cash, cash equivalents, and restricted cash (2,863) (5,636) 5,306
Cash, cash equivalents, and restricted cash at beginning of period 3,640 9,276 3,970
Cash, cash equivalents, and restricted cash at end of period 777 3,640 9,276
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:      
Cashless exercise of warrants $ 35 $ 14,265